Skip to content

An mHealth Intervention to Improve Outcomes for Women With HIV/AIDS

A Multi-Lingual, Culturally-Competent Mobile Health Intervention to Reduce Medical Mistrust, Stigma, and Improve Treatment Adherence Among Women Living With HIV/AIDS (WLWH)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03738410
Enrollment
80
Registered
2018-11-13
Start date
2022-05-02
Completion date
2027-07-31
Last updated
2026-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS

Keywords

mHealth, mobile applications, culturally-competent, HIV stigma, Resilience

Brief summary

The purpose of this study is: 1. To develop a new mobile health (mHealth) system that will send text messages to remind both pregnant and non-pregnant women with HIV to adhere to their treatment plan (like keeping appointments, fillings prescriptions, and taking their medication) and address individual barriers to HIV care (like stigma, medical mistrust and resilience). 2. The intervention will also include patient navigation and motivational interviewing 2\) Investigators also want to see if the mHealth system is feasible, easily accepted and if it will impact patient health in a positive way.

Interventions

BEHAVIORALMobile Health Messaging application

Mobile messaging sent to participants over a 12-month period.

OTHERStandard of Care Treatment

Standard of care (SOC) is defined as the usual care a licensed health care provider would give patients to treat HIV/AIDS. SOC associated procedures and policies may vary across clinical settings.

Sponsors

University of Miami
Lead SponsorOTHER
National Institute on Drug Abuse (NIDA)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

This is a qualitative/quantitative trial that utilizes a Sequential to Parallel intervention study design model. The initial 15 participants (first 5 each that speak English, Spanish, or Haitain Creole) will participate in the Qualitative arm. These participants may also be eligible to roll over into the quantitative portion of the study and randomized to either the control group or the mHealth Intervention group.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Confirmed HIV diagnosis as per the clinic standard * Female \>= 18 years old at enrollment * Currently active or recently returned into care or newly enrolled * With two or more previously scheduled visits (12 months prior to study enrollment * in the 12 months prior to enrollment: * missed one or more visits or * viral load detectable (\>20 mL) or * not taking prescribed HIV anti-retroviral medications

Exclusion criteria

* men * women who are cognitively impaired or are not able to consent for themselves * non-working cell phone * adolescents \< 18 years old at enrollment

Design outcomes

Primary

MeasureTime frameDescription
Rate of EnrollmentMonth 12The proportion of participants enrolled and proportion of participants declined enrollment or screen failed out of total number of participants approached.
Acceptability of the mHealth applicationMonth 12The proportion of messages opened, which were received

Secondary

MeasureTime frameDescription
Change in Clinic AttendanceBaseline, Month 12Change in attendance to HIV primary care visits within 12 months of randomization
Change in HIV StigmaBaseline, Month 12Change in measured stigma (AIDS-related Stigma Scale) within 12 months of randomization (range 40=strongly disagree to 160=strongly agree).
Change in Medical MistrustBaseline, Month 12Change in measured medical mistrust (Group-based Medical Mistrust) within 12 months of randomization (range 12=does not agree at all to 60=completely agrees).
Change in ResilienceBaseline, Month 12Change in measured resiliency (Connor-Davidson Resiliency Scale) within 12 months of randomization (range 0=not true at all to 100=true nearly all of the time).

Countries

United States

Contacts

CONTACTLunthita M Duthely, Ed.D.
lduthely@med.miami.edu305-243-5800
PRINCIPAL_INVESTIGATORLunthita M Duthely, Ed.D.

University of Miami

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 26, 2026